Magnetic Resonance Angiography Market - Global Forecast 2026-2032

The Magnetic Resonance Angiography Market is projected to reach USD 3.92 Billion in 2026. It is expected to continue growing at a CAGR of 11.57%, reaching USD 7.67 Billion by 2032.

Magnetic Resonance Angiography (MRA) is a specialized vascular imaging technique that uses MRI physics to visualize arteries and veins without ionizing radiation. It supports assessment of cerebrovascular disease, peripheral artery disease, renal artery stenosis, aortic pathology, congenital vascular anomalies, and pre-surgical vascular mapping. As healthcare systems prioritize earlier diagnosis and longitudinal monitoring, MRA is gaining relevance as a non-invasive alternative or complement to computed tomography angiography and catheter-based angiography.

The magnetic resonance angiography market is shaped by demand for high-quality vascular imaging, installed MRI capacity, clinical preference for radiation-free diagnostics, and innovation in contrast-enhanced and non-contrast MRA sequences. Adoption is strongest where advanced radiology infrastructure, trained MRI technologists, reimbursement pathways, and cardiovascular and neurovascular care networks are well established. According to the World Health Organization, cardiovascular diseases remain the leading cause of death globally, reinforcing the clinical need for accurate vascular imaging across acute care, chronic disease management, and interventional planning.

Transformative Shifts in the MRA Landscape

The MRA landscape is shifting from procedure-centered imaging toward integrated vascular care pathways. Hospitals and diagnostic imaging centers are using MRA for stroke workups, aneurysm evaluation, peripheral vascular assessment, and follow-up of chronic vascular conditions, while radiology teams seek faster protocols that improve scanner throughput without compromising diagnostic confidence.

Technology development is also changing competitive dynamics. Non-contrast MRA is becoming more important because it can reduce reliance on gadolinium-based contrast agents in patients with renal impairment or repeated imaging needs. At the same time, high-field MRI systems, advanced coils, parallel imaging, compressed sensing, and motion-correction techniques are improving image quality and shortening acquisition times, strengthening MRA’s role in precision vascular imaging. These shifts align with broader healthcare priorities around radiation reduction, contrast-agent stewardship, value-based imaging, and standardized reporting for vascular disease.

Cumulative Impact of Artificial Intelligence in MRA

Artificial intelligence is having a cumulative impact across MRA acquisition, reconstruction, interpretation, and workflow orchestration. AI-enabled reconstruction and denoising can support shorter scan times and more consistent image quality, while automated vessel segmentation, stenosis quantification, and anomaly detection tools are designed to improve radiologist efficiency and reproducibility.

Regulatory activity confirms that AI is no longer experimental in medical imaging; the U.S. FDA maintains an expanding list of cleared AI-enabled medical devices, with radiology representing the largest category. For MRA, the most practical near-term value is expected in protocol optimization, triage of suspected vascular abnormalities, quantitative reporting, and integration with enterprise imaging systems, provided models are validated across scanner vendors, patient populations, and clinical settings. Successful deployment also depends on transparent performance monitoring, cybersecurity controls, interoperability with picture archiving and communication systems, and clinician oversight to minimize bias and preserve diagnostic accountability.

Key Regional Insights for Magnetic Resonance Angiography

North America remains a leading region for magnetic resonance angiography due to mature MRI infrastructure, strong neuroradiology and cardiovascular imaging capabilities, and established reimbursement mechanisms in the United States and Canada. The United States benefits from high specialist density, comprehensive stroke centers, and large academic medical centers, while Canada’s publicly funded system supports demand through stroke, vascular surgery, oncology, and chronic disease pathways.

Europe shows broad adoption supported by universal or mixed healthcare systems, strong radiology societies, and advanced hospital networks across Germany, France, the United Kingdom, Italy, and Spain. The European Union’s emphasis on medical device regulation, post-market surveillance, data protection, and evidence-based procurement also influences purchasing decisions, AI deployment, and contrast-agent stewardship. Russia continues to support MRA demand through large hospital systems and specialist diagnostic centers.

Asia-Pacific is a fast-evolving opportunity base as China, Japan, India, South Korea, Australia, and ASEAN countries expand MRI access, tertiary care capacity, and advanced diagnostics. Japan and South Korea benefit from high-technology healthcare environments, China is scaling high-end imaging infrastructure, India is expanding access in metropolitan and tier-2 cities, and Australia maintains strong use through public-private specialist referral networks. Latin America, led by Brazil and Mexico, shows momentum in private imaging networks and tertiary hospitals, while the Middle East benefits from healthcare modernization in GCC markets, hospital digitization, and investment in specialist care. Africa remains comparatively underpenetrated, with MRA demand concentrated in major urban hospitals, academic centers, and private diagnostic facilities where MRI availability and specialist interpretation are accessible.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are expanding access to MRI through public hospital upgrades and private diagnostic investment, particularly in urban centers. Demand for MRA is tied to rising cardiovascular risk, diabetes prevalence, stroke burden, and the need for advanced neurovascular imaging, although uneven reimbursement, scanner availability, and radiologist workforce constraints continue to shape adoption.

The GCC is investing in tertiary care, medical tourism, and digital health infrastructure, making it a high-potential group for advanced MRI angiography systems and AI-enabled imaging workflows. The European Union prioritizes safety, interoperability, privacy, clinical evidence, and regulatory compliance, creating demand for validated MRA protocols, harmonized reporting, and AI solutions that meet medical device and data governance requirements.

BRICS countries represent a scale-driven opportunity, with China and India expanding diagnostic capacity, Brazil strengthening private imaging access, Russia maintaining specialized hospital networks, and South Africa serving as a regional hub for advanced tertiary care. G7 countries remain innovation leaders due to installed MRI capacity, academic research output, aging populations, and reimbursement maturity, while NATO countries benefit from broader healthcare and defense-linked requirements for trauma, vascular assessment, rehabilitation, and advanced imaging readiness.

Key Country Insights for MRA Adoption

The United States is the largest and most innovation-driven MRA market, supported by academic radiology, certified stroke centers, vascular surgery programs, broad MRI availability, and an active FDA pathway for imaging AI. Canada’s demand is shaped by publicly funded imaging access, provincial investment cycles, and clinical prioritization of stroke, cancer, and vascular disease pathways, while Mexico and Brazil are led by private hospitals, diagnostic chains, and tertiary urban centers serving populations with growing cardiometabolic disease burden.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong clinical use of MRA across neurovascular, aortic, renal, and peripheral vascular indications. Germany benefits from advanced imaging infrastructure and specialist hospital networks, France from centralized healthcare planning and strong clinical governance, and the United Kingdom from national pathways for stroke and vascular care. Italy and Spain support demand through public hospital systems and regional specialty centers, while Russia retains MRA utilization through large hospital systems, academic institutions, and specialist centers.

Asia-Pacific country dynamics are diverse. China is scaling high-end imaging capacity and domestic medical technology development, India is expanding MRI access in metropolitan and tier-2 cities, Japan has advanced MRI adoption and aging-related vascular demand, South Korea combines hospital digitization with high technology uptake, and Australia maintains strong demand through specialist referral networks and public-private healthcare delivery. Across these countries, MRA adoption is most closely linked to MRI availability, reimbursement clarity, subspecialty radiology capacity, stroke preparedness, and the ability to integrate advanced protocols into routine clinical workflows.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize faster, standardized MRA protocols that improve scanner utilization and reduce patient motion-related repeat scans. Vendors and providers can strengthen adoption by offering optimized protocol libraries for neurovascular, renal, aortic, and peripheral vascular imaging across 1.5T and 3T MRI systems.

Commercial strategies should emphasize non-contrast MRA capabilities, AI-assisted workflow tools, and evidence demonstrating diagnostic performance, patient safety, and operational efficiency. Partnerships with academic medical centers, stroke networks, vascular surgery departments, and cloud-based imaging platforms can accelerate validation, implementation, and clinical acceptance.

Executives should also align product development with regulatory expectations, cybersecurity requirements, data protection rules, and interoperability standards. In emerging markets, financing models, radiographer training, service uptime, remote reading partnerships, and structured education for referring clinicians can be as important as scanner specifications in driving sustainable adoption.

Research Methodology

This executive summary is developed using a structured secondary and primary research framework, combining publicly available evidence with validated market interpretation. Secondary sources include regulatory databases, healthcare agency publications, radiology society guidance, peer-reviewed medical literature, hospital procurement signals, reimbursement references, and macroeconomic healthcare indicators.

The methodology evaluates magnetic resonance angiography across technology type, contrast use, clinical application, end user, geography, and competitive positioning without relying on market estimation, market sizing, market share, or forecasting. Insights are triangulated through source validation, trend comparison, and consistency checks against established clinical practice, including guidance from organizations such as the FDA, EMA, ACR, RSNA, OECD, and WHO where relevant.

Conclusion

Magnetic Resonance Angiography is positioned for sustained relevance as healthcare systems seek accurate, non-invasive, and radiation-free vascular imaging. Demand is supported by cardiovascular and neurovascular disease burden, aging populations, the need for follow-up imaging, and continued investment in MRI infrastructure.

The next phase of adoption will be defined by faster acquisition, non-contrast techniques, AI-enabled reconstruction and interpretation, and region-specific access strategies. Organizations that combine clinical evidence, operational efficiency, regulatory compliance, and interoperable digital integration will be best positioned to lead in the evolving MRA market.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Magnetic Resonance Angiography Market, by Product Type

7.1. Introduction
7.2. Accessories
7.2.1. Coils
7.2.2. Injectors
7.2.3. Patient Monitoring Devices
7.3. MRA Systems
7.4. Contrast Agents
7.4.1. Gadolinium-based Agents
7.4.2. Iron Oxide Nanoparticles
7.5. Software

8. Magnetic Resonance Angiography Market, by Technology

8.1. Introduction
8.2. Contrast Enhanced MRA
8.2.1. Time-of-Flight (TOF)
8.2.2. Phase Contrast (PC)
8.3. Non Contrast Enhanced MRA

9. Magnetic Resonance Angiography Market, by Field Strength

9.1. Introduction
9.2. Low Field MRI
9.3. Mid Field MRI
9.4. High Field MRI

10. Magnetic Resonance Angiography Market, by Application

10.1. Introduction
10.2. Cardiac & Thoracic Vessels
10.2.1. Coronary Artery Imaging
10.2.2. Aortic Imaging
10.2.3. Pulmonary Artery Imaging
10.3. Neurovascular
10.3.1. Stroke Diagnosis
10.3.2. Aneurysm Detection
10.3.3. Carotid Artery Imaging
10.4. Peripheral Vascular
10.4.1. Lower Extremity Arteries
10.4.2. Upper Extremity Arteries
10.5. Renal Angiography
10.6. Abdomen Imaging

11. Magnetic Resonance Angiography Market, by End User

11.1. Introduction
11.2. Hospitals
11.3. Academic & Research Institute
11.4. Ambulatory Surgical Centers
11.5. Diagnostic Imaging Centers

12. Magnetic Resonance Angiography Market, by Region

12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa

13. Magnetic Resonance Angiography Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Magnetic Resonance Angiography Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. Competitive Landscape

15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025

16. Company Profiles

16.1. Agfa-Gevaert N.V.
16.2. Aspect Imaging Ltd.
16.3. Aurora Imaging Technology, Inc.
16.4. Bruker Corporation
16.5. Canon Medical Systems Corporation
16.6. Carestream Health, Inc.
16.7. CurveBeam AI, Inc.
16.8. Esaote S.p.A.
16.9. FUJIFILM Holdings Corporation
16.10. GE HealthCare Technologies Inc.
16.11. Hyperfine, Inc.
16.12. IMRIS Inc.
16.13. Koninklijke Philips N.V.
16.14. Mediso Ltd.
16.15. MR Solutions Ltd.
16.16. Nano-X Imaging Ltd.
16.17. Neusoft Medical Systems Co., Ltd.
16.18. Samsung Medison Co., Ltd.
16.19. Shenzhen Anke High-tech Co., Ltd.
16.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.21. Shimadzu Corporation
16.22. Siemens Healthineers AG
16.23. Synaptive Medical Inc.
16.24. Time Medical Systems Co., Ltd.
16.25. United Imaging Healthcare Co., Ltd.

List of Figures

FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ACCESSORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ACCESSORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MRA SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MRA SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MRA SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONTRAST AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONTRAST AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CONTRAST AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL GADOLINIUM-BASED AGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL IRON OXIDE NANOPARTICLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CONTRAST ENHANCED MRA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TIME-OF-FLIGHT (TOF) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PHASE CONTRAST (PC) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL NON CONTRAST ENHANCED MRA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL LOW FIELD MRI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LOW FIELD MRI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LOW FIELD MRI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MID FIELD MRI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MID FIELD MRI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MID FIELD MRI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL HIGH FIELD MRI MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL HIGH FIELD MRI MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL HIGH FIELD MRI MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIAC & THORACIC VESSELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CORONARY ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL AORTIC IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AORTIC IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AORTIC IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PULMONARY ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL NEUROVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ANEURYSM DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CAROTID ARTERY IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PERIPHERAL VASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LOWER EXTREMITY ARTERIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL UPPER EXTREMITY ARTERIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL RENAL ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL ABDOMEN IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ACADEMIC & RESEARCH INSTITUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 147. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 148. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 150. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 151. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 153. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 154. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 155. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 171. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 172. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 173. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 174. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 175. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 176. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 177. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 178. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 179. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 184. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 185. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 186. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 187. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 188. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 190. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 191. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 192. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 196. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 197. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 199. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 200. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 202. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 203. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 204. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 220. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 221. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 223. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 224. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 225. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 226. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 227. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 228. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 231. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 232. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 233. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 235. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 236. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 238. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 239. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 240. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 244. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 245. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 247. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 248. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 250. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 251. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 252. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 254. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 269. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 270. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 271. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 272. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 273. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 275. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 276. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 277. CANADA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 281. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 282. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 283. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 284. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 285. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 287. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 288. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 289. MEXICO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 293. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 316. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 317. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 318. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 319. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED MRA, 2017-2032 (USD MILLION)
TABLE 320. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2017-2032 (USD MILLION)
TABLE 321. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC & THORACIC VESSELS, 2017-2032 (USD MILLION)
TABLE 323. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 324. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2017-2032 (USD MILLION)
TABLE 325. GERMANY MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES, 2017-2032 (USD MILLION)
TABLE 329. FRANCE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST AGENTS, 2017-2032 (USD MILLION)
TABLE 330. FRANCE MAGNETIC RESONANCE AN

Companies Mentioned

Agfa-Gevaert N.V.
Aspect Imaging Ltd.
Aurora Imaging Technology, Inc.
Bruker Corporation
Canon Medical Systems Corporation
Carestream Health, Inc.
CurveBeam AI, Inc.
Esaote S.p.A.
FUJIFILM Holdings Corporation
GE HealthCare Technologies Inc.
Hyperfine, Inc.
IMRIS Inc.
Koninklijke Philips N.V.
Mediso Ltd.
MR Solutions Ltd.
Nano-X Imaging Ltd.
Neusoft Medical Systems Co., Ltd.
Samsung Medison Co., Ltd.
Shenzhen Anke High-tech Co., Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Synaptive Medical Inc.
Time Medical Systems Co., Ltd.
United Imaging Healthcare Co., Ltd.

Table Information

Report Attribute	Details
No. of Pages	191
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 3.92 Billion
Forecasted Market Value ( USD ) by 2032	$ 7.67 Billion
Compound Annual Growth Rate	11.5%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the MRA Landscape

Cumulative Impact of Artificial Intelligence in MRA

Key Regional Insights for Magnetic Resonance Angiography

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Key Country Insights for MRA Adoption

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cerebral Angiography - Global Strategic Business Report

Magnetic Resonance Angiography Market Outlook 2026-2034: Market Share and Growth Analysis by Technique (Contrast Enhanced MRA, Non-contrast Enhanced MRA), Application, End User

Cerebral Angiography Market - Global Forecast 2026-2032

Magnetic Resonance Angiography Market 2025-2029

Angiography Devices Market Insights, Competitive Landscape, and Market Forecast - 2033